AZAB MOHAMMAD

CIK 00013096535 companiesBASKING RIDGE, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001309653

Recent Transactions

50 trades

Award
LISATA THERAPEUTICS, INC.$LSTA
Common Stock
2026-01-09+30,456→ 104,925 total
Disposition from Tender
DURECT CORP
Common Stock
2025-09-11−6,000→ 0 total
Disposition to Issuer
DURECT CORP
Stock Option (right to buy)
2025-09-11−2,750→ 0 total
Disposition to Issuer
DURECT CORP
Stock Option (right to buy)
2025-09-11−5,500→ 0 total
Disposition to Issuer
DURECT CORP
Stock Option (right to buy)
2025-09-11−5,500→ 0 total
Disposition to Issuer
DURECT CORP
Stock Option (right to buy)
2025-09-11−7,000→ 0 total
Disposition to Issuer
DURECT CORP
Stock Option (right to buy)
2025-09-11−5,500→ 0 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Common Stock
2025-01-09+15,789→ 74,469 total
Award
DURECT CORP
Stock Option (right to buy)
2024-09-25+5,500→ 5,500 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Common Stock
2024-01-09+19,480→ 58,680 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-12-19$9.85/sh+823→ 70,728 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-12-19−3,497→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-12-19$9.85/sh+3,497→ 74,225 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-12-19−823→ 0 total
Award
DURECT CORP
Stock Option (right to buy)
2023-06-21+5,500→ 5,500 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-06-02+18,475→ 18,475 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Common Stock
2023-01-09+20,000→ 39,200 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-12-12−3,086→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-12-12$2.68/sh+3,086→ 69,905 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Common Stock
2022-09-15$6.25/sh+19,200→ 19,200 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-06-28+18,000→ 18,000 total
Award
DURECT CORP
Stock Option (right to buy)
2022-06-15+55,000→ 55,000 total
Purchase
DURECT CORP
Common Stock
2022-05-24$0.39/sh+5,000→ 40,000 total
Purchase
DURECT CORP
Common Stock
2022-05-24$0.38/sh+5,000→ 45,000 total
Purchase
DURECT CORP
Common Stock
2022-05-24$0.39/sh+5,000→ 60,000 total
Purchase
DURECT CORP
Common Stock
2022-05-24$0.39/sh+10,000→ 55,000 total
Purchase
DURECT CORP
Common Stock
2022-05-24$0.39/sh+5,000→ 35,000 total
Purchase
DURECT CORP
Common Stock
2022-05-17$0.42/sh+9,300→ 19,300 total
Purchase
DURECT CORP
Common Stock
2022-05-17$0.42/sh+8,900→ 28,200 total
Purchase
DURECT CORP
Common Stock
2022-05-17$0.42/sh+1,800→ 30,000 total
Purchase
DURECT CORP
Common Stock
2022-05-16$0.38/sh+10,000→ 10,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-12-15$3.67/sh+3,086→ 66,819 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-12-15−3,086→ 0 total
Award
DURECT CORP
Stock Option (right to buy)
2021-06-15+27,500→ 27,500 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-06-03+10,000→ 10,000 total
Award
DURECT CORP
Stock Option (right to buy)
2021-01-04+70,000→ 70,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2020-12-15$3.76/sh+3,086→ 63,733 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2020-12-15−3,086→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2020-06-01+10,000→ 10,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-12-16−3,086→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-12-16$3.56/sh+3,086→ 60,647 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-09-16+15,000→ 15,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-09-13$9.31/sh−23→ 57,561 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2018-12-06$3.07/sh+3,086→ 57,584 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2018-12-06−3,086→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2018-06-21−10,288→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2018-06-21$3.70/sh+10,288→ 54,498 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2018-06-04+15,000→ 15,000 total
Purchase
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2017-11-15$2.22/sh+15,000→ 44,210 total
Purchase
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2017-09-22$2.95/sh+8,000→ 29,210 total

Companies

Recent Filings

Address

C/O LISATA THERAPEUTICS, INC, 110 ALLEN ROAD, 2ND FLOOR

BASKING RIDGE, NJ, 07920

View on SEC.gov